ArticleMilitary medicine2026
Soil-Dwelling Bacteria Display Tolerance Against Typical Antibiotic Serum Levels in an Ex Vivo Model of Traumatized Tissue.
Article in Military medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Soft-tissue reconstruction timing in ballistic lower extremity open fractures: impact on osteomyelitis and union.Journal of orthopaedic surgery and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionMilitary wounds often contain large amounts of necrotic, avascular tissue that provide an ideal home for environmental and endogenous flora to dwell. Debridement mitigates infection but cannot be performed until the casualty is transported to a surgically equipped site, sometimes days after initial injury. Meanwhile, opportunistic pathogens spread throughout the wound site. Systemic antibiotic therapies fail to eradicate these soil microorganisms potentially because they dwell in an antibiotic-tolerant phenotype. Laboratory tests that incorporate environment soil may promote the development of point-of-care therapies effective against biofilm-like organisms. We hypothesized that, in an ex vivo model of traumatized tissue, blood-serum antibiotic concentrations would fail to eradicate soil-dwelling organisms. MATERIALS AND
methodsSterile, excised tissue was collected from concurrent sheep studies. Tissue samples were coated with topsoil that was confirmed to contain naturally occurring viable organisms, then blasted with an air cannon to simulate trauma and distribute soil throughout. The tissue test environment was then moved into a 6 well-plate for treatment with saline suspensions of systemic levels of antimicrobials, or a 10× concentration of the same. Following a 24-hour incubation, tissues and remaining treatment was diluted and quantified on selective and non-selective agar plates. Colony forming units (CFU)/g of tissue were calculated between agar type and treatment group than compared using a Student's t-test.
resultsNon-treated, soil-contaminated tissues had an average of 8.43 ± 0.36 log10 CFU/g tissue. Fungal species were the most common organism cultured among all groups, though this may change between soil samples. Serum-level antimicrobials failed to reduce bioburden to a significant degree. Only 10× systemic concentrations achieved statically significant (P < .001) bioburden reduction and lowered organisms to below 5 log10 CFU/g tissue.
conclusionsOutcomes suggested that antimicrobial levels that would typically be administered prophylactically fail to kill soil microbes dwelling in compromised tissue. The findings support the premise for local, high-dose antimicrobial therapies capable of managing biofilm-life bacterial contamination. These results translate towards improved triage methods: to prolong the time from injury to debridement, anti-infective technologies must have the potential to kill organisms that otherwise tolerate low levels of antimicrobials. Systemic prophylaxis alone may be insufficient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.